Oxford Vaccine Group applies for consent to perform a deliberate release of a genetically modified vaccine

Oxford Vaccine Group has applied to Defra for consent to perform a deliberate release of a genetically modified vaccine against paratyphoid fever (VASP) for research and development purposes.

Part A1-6: Information required under schedule 2 of the Genetically Modified (Deliberate Release) Regulations 2002

PDF, 394 KB, 56 pages

Part B: Information about the release application to be included on the public register

PDF, 81.9 KB, 7 pages

We invite representations on any risks of damage being caused to the environment by the release applied for in this application (reference 20/R48/01a). You can make representation by either:

• emailing gm-regulation@defra.gov.uk - please include the application reference number in the e-mail title
• writing to the GM Team and stating the application reference number:

GM Team
Department for Environment, Food and Rural Affairs
Second Floor
Seacole Building
Marsham Street
London
SW1P 4DF